Viviant FDA Approval Status
FDA Approved: No
Brand name: Viviant
Generic name: bazedoxifene
Company: Pfizer Inc.
Treatment for: Prevention of Osteoporosis
Viviant (bazedoxifene) is a selective estrogen receptor modulator (SERM) in development for the prevention of postmenopausal osteoporosis.
Development Timeline for Viviant
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.